INMB - INmune Bio - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

89.57M

Cash

47.83M

Avg Qtr Burn

-3.344M

Short % of Float

9.57%

Insider Ownership

35.07%

Institutional Own.

12.05%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
XPro1595 (XPro™) Details Alzheimer's disease	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
LIVNate Details NASH-induced significant or severe fibrosis, Liver disease	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INB03 + trastuzumab-deruxtecan Details Cancer, Pancreatic cancer, HER2-expressing cancers, Breast cancer, Triple-negative breast cancer , Gastric cancer	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
XPro1595 (XPro™) (pegipanermin fr) Details Major depressive disorder, Mental health, Treatment Resistant Depression	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INKmune™ Details Cancer, Prostate cancer, Castration-resistant prostate cancer	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
INKmune™ Details Cancer, Myelodysplastic syndrome, Acute myeloid leukemia	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Quellor™ Details COVID-19	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.